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Abstract Leptin (OB) exerts weight-reducing effects in mice. 
The structure of the receptor for this factor, OB-R, is 
considerably similar to those of gpl30, the common signal 
transducing receptor component for the interleukin-6 (IL-6) 
family of cytokines, and leukemia inhibitory factor receptor 
(LIFR). Since the IL-6 family of cytokines signal through gpl30 
homodimer or gpl30/LIFR heterodimer, we have examined in 
this study the possible involvement of gpl30 and LIFR in leptin 
signaling through OB-R. Leptin stimulation induces tyrosine 
phosphorylation of neither gpl30 nor LIFR, while LIF stimula-
tion does both. As examined by using two differently epitope-
tagged OB-R molecules, the spontaneous homo-oligomerization 
of OB-R has been elucidated. Ba/F3 cells, which do not express 
gpl30, are non-responsive to leptin and exhibit increased DNA 
synthesis in response to leptin after transfection of OB-R cDNA 
alone. OB-R appears to transduce the signal via its homo-
oligomerization without interaction with gpl30 or LIFR. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The mouse obesity gene encodes an adipose tissue derived 
signaling factor, OB or leptin [1], for body weight homeostasis 
[2-A]. Recently, the receptor for this factor, OB-R, was cloned 
and it has been revealed that this receptor belongs to the class 
I cytokine receptor family and shows the highest similarity to 
gpl30 which is the common signal transducer for the inter-
leukin 6 (IL-6) family of cytokines [5]. 
IL-6, leukemia inhibitory factor (LIF), oncostatin M 
(OSM), ciliary neurotrophic factor (CNTF), IL-11 and 
cardiotrophin-1 (CT-1) are a subset of cytokines with struc-
tural and functional similarity [6,7]. A complex of IL-6 and 
IL-6 receptor (IL-6R) or IL-11 and IL-11R associates with 
gpl30, allowing it to homodimerize [8-10]. LIF binds to 
LIFR, whose structure is closely related to that of gpl30, 
leading to its heterodimerization with gpl30 [11,12]. The for-
mation of the heterodimer of the same composition, i.e. LIFR 
and gpl30, is also triggered by OSM [12,13], CT-1 [14] and a 
complex of CNTF and its receptor, CNTFR [15,16]. Thus, all 
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the IL-6 family of cytokines can signal through gpl30 protein 
dimerized with itself or with its close relative, LIFR. Taken 
together with the recent observation that OB-R is most re-
lated to gpl30 and LIFR, we have investigated the possible 
involvement of gpl30 and LIFR in leptin signal transduction 
through OB-R. 
The extracellular region of these three receptor components 
is composed of either six or eight fibronectin type III modules 
and contains four conserved cysteine residues and a trypto-
phan-serine-X-tryptophan-serine (X represents any amino 
acid) motif that are conserved in the class I cytokine receptor 
family [5,17]. The cytoplasmic regions of OB-R, gpl30 and 
LIFR possess three conserved motifs, boxi, box2 and box3 in 
the membrane-proximal-to-distal order [5,18,19]. In the case 
of gpl30, mutational analyses have indicated that the boxi 
motif is important for the association with Janus kinases 
(JAKs) and that the box2 motif plays a critical role, in concert 
with boxi, in inducing DNA synthesis [18,20,21]. The box3 
contains a tyrosine-X-X-glutamine (Y-X-X-Q) motif which is 
proposed as a docking site for the signal transducer and acti-
vator of transcription 3 (STAT3) [22]. STAT3 is a transcrip-
tion factor which was originally characterized to bind to the 
IL-6-responsive element in, for instance, the acute phase pro-
tein genes and to induce their transcription [23-25]. Dimeriza-
tion of gpl30 itself or with LIFR triggers the activation of 
JAKs, and activated JAKs phosphorylate tyrosine residues in 
gpl30 and LIFR [8,16,20,21]. STAT3 is recruited to the phos-
phorylated Y-X-X-Q motif through its Src homology (SH) 2 
domain, and this recruitment leads to tyrosine phosphoryla-
tion of STAT3 by JAKs and subsequent transcriptional acti-
vation [22,26]. Besides STAT3, STATI is tyrosine phosphoryl-
ated when high doses of IL-6 are used for gpl30 stimulation 
[27], although direct binding between STATI and gpl30 has 
not yet been demonstrated. 
In leptin-nonresponsive obesity mutant mice (dbldb mice), a 
short form of OB-R which lacks most of the cytoplasmic 
region and retains only the boxi motif and its vicinity is pre-
dominantly expressed, and the long, complete form of OB-R 
which contains its entire cytoplasmic region is hardly ex-
pressed because of the generation of an aberrant splice donor 
site by a guanine to thymine base substitution [28-30]. Recent 
reports showed that STATI, 3, 5 and 6 are activated through 
the long form but not the short form of OB-R and suggested 
that the lack of the long form of OB-R is responsible for dbldb 
mice phenotype [31,32]. 
Based on the structural similarity in OB-R and gpl30 and 
their common ability to activate STATI and STAT3 proteins, 
the possibility has arisen that OB-R might utilize gpl30 or 
LIFR as a signal-transducing component. We have examined 
in this study whether OB-R interacts with gpl30 or LIFR and 
whether it homodimerizes as does gp!30. 
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2. Materials and methods 
2.1. Materials 
Recombinant human IL-6 and soluble IL-6R (sIL-6R) were kindly 
provided by Dr. K. Yasukawa, Tosoh, Kanagawa, Japan. Human 
LIF was a gift from Genetics Institute, Cambridge, MA. Recombi-
nant human leptin expressed in E. coli was provided by Dr. F. de 
Sauvage, Genentech Inc., CA [33]. Anti-OB-R antibody was produced 
by immunizing rabbits with recombinant soluble extracellular domain 
of the human OB-R expressed in 293 cells and was also a gift from 
Genentech Inc. Anti-STAT3 antibody was generously provided by Dr. 
S. Akira (Hyogo College of Medicine, Hyogo, Japan). Anti-gpl30 
antibody was prepared as described previously [34]. Antibodies to 
LIFR, phosphotyrosine (4G10), FLAG, and c-Myc were purchased 
from Santa Cruz Biotechnologies (Santa Cruz, CA), Upstate Biotech-
nology Inc. (Lake Placid, NY), IBI (New Haven, CT), and Zeneca 
(Wilmington, DE), respectively. 
2.2. Plasmici construction 
Complementary DNAs encoding human gpl30 [34] and human 
STAT3 [24] were subcloned into a mammalian expression vector 
pEF-BOS (generous gift from Dr. S. Nagata, Osaka University, Osa-
ka, Japan). The long form of human OB-R cDNA was a kind gift 
from Genentech Inc. [35,36]. Complementary DNA encoding the long 
form of OB-R was also subcloned into pEF-BOS or pRK5 [36]. Either 
a FLAG tag (DYKDDDDK) or a c-Myc tag (EQKLISEEDLLR) 
was carboxyl-terminally appended at Pro-877 of OB-R protein by 
the PCR method. The expression of the long form OB-R in COS7 
cells was very much attenuated when these tags were introduced. For 
the experiments to examine OB-R oligomer formation, we thus used 
the tagged truncated OB-R constructs that have the extracellular, 
transmembrane and membrane-proximal cytoplasmic regions identical 
to those of the long form OB-R. 
2.3. Transfection and immunoblot analysis 
Mouse pro-B cell line Ba/F3 cells were cultured in RPMI medium 
(containing 10% fetal calf serum and 5% WEHI 3B condition medium 
as a source of IL-3) and transfected with the long form OB-R expres-
sion construct in pRK5 by an electroporation method and neomycin-
resistant clones were selected in growth medium containing Geneticin 
(Gibco BRL, Grand Island, NY) at 2 mg/ml as described elsewhere 
Fig. 2. Coimmunoprecipitation of two differently epitope-tagged 
OB-R molecules. COS7 cells were transfected with either FLAG-
tagged OB-R (OBF) or c-Myc-tagged OB-R (OBM) cDNA con-
struct or both. Cells were incubated with (+) or without (—) leptin. 
Lysates were immunoprecipitated with either anti-FLAG or c-Myc 
antibody, and then analyzed by Western blotting using anti-FLAG 
and c-Myc antibodies. 
[36]. Cell surface expression of OB-R was confirmed by flow cytom-
etry using anti-OB-R antibody. 
COS7 cells were maintained in Dulbecco's modified Eagle's medium 
containing 10% fetal calf serum and transfected using a DEAE-dex-
tran method with cDNAs in pEF-BOS. Prior to stimulation with 
cytokines, transfected COS7 cells were starved for 4 h in medium 
without serum and then stimulated for 10 min with leptin (50 ng/ 
ml), a combination of IL-6 and sIL-6R (50 ng/ml), or LIF (50 ng/ 
ml). The cells were solubilized with Nonidet P-40 (NP-40) lysis buffer 
(0.5% NP-40/10 mM Tris-HCl, pH7.6/150 mM NaCl/5 mM EDTA/2 
mM NaßVO^l mM phenylmethylsulfonyl fluoride/5 ug of aprotinin 
per ml), and then subjected to immunoprecipitation and immunoblot-
ting as described in [21]. 
2.4. DNA synthesis analysis 
Ba/F3 cell [3H]thymidine incorporation assay was performed as 
described previously [36]. 
3. Result 
Fig. 1. OB-R stimulation does not induce tyrosine phosphorylation 
of gpl30 or LIFR. (A) COS7 cells were transfected with OB-R 
along with gpl30 and STAT3. Cells were treated with medium 
alone or the cytokines indicated. gpl30 was immunoprecipitated 
with anti-gpl30 antibody and probed with either anti-phosphotyro-
sine (top) or anti-gpl30 (middle) antibody. (Bottom) STAT3 was 
immunoprecipitated with anti-STAT3 antibody and probed with 
anti-phosphotyrosine antibody. (B) COS7 cells transfected with the 
same set of constructs as in (A) were treated with medium alone, 
leptin or LIF. Lysates were immunoprecipitated with anti-phospho-
tyrosine antibody and subsequently immunoblotted with anti-LIFR 
antibody (upper). Total cell lysates were subjected to Western analy-
sis using anti-LIFR antibody (lower). 
3.1. Inability of OB-R stimulation to induce tyrosine 
phosphorylation of gpl30 or LIFR 
All the IL-6 family of cytokines can signal through gpl30 
protein which is dimerized with itself or with closely related 
L I F R [6-16]. In addition, OB-R shows high structural simi-
larity to gpl30 and L I F R proteins [5]. The possibility thus 
arises that OB-R may interact with gpl30 or L I F R for its 
signal transduction. Since tyrosine phosphorylation of gpl30 
or gpl30 together with L I F R is the first event in the signal 
transduction of the cytokines that induce gpl30 homodimer 
or gp l30 /LIFR heterodimer, respectively [8,16], we examined 
whether either of these two molecules are tyrosine phospho-
rylated following OB-R stimulation. COS7 cells were trans-
fected with expression constructs for OB-R along with gpl30 
and STAT3. Cells were treated with medium alone, leptin, a 
complex of IL-6 and soluble IL-6R (sIL-6R) which is known 
to homodimerize gp l30 [8,37], or L I F . Lysates were immuno-
precipitated with ant i-gpl30 antibody and immunoblotted 
with anti-phosphotyrosine antibody. As shown in Fig. 1A 
(top), tyrosine phosphorylation of gp l30 was detected in cells 
stimulated with IL-6 plus sIL-6R. The L I F stimulation in-
duced tyrosine phosphorylation of gp l30 as well as coimmu-
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Fig. 3. Promotion of DNA synthesis in OB-R-expressing Ba/F3 cells 
in response to leptin. Ba/F3 cells and those transfected with the 
long form OB-R cDNA were cultured in medium alone (empty 
bars) or leptin (hatched bars) for 24 h. After pulse labeling with 
[3H]thymidine, incorporated radioactivities were measured. 
noprecipitated endogenous LIFR. No significant tyrosine 
phosphorylation of gpl30 was detectable in the leptin-
stimulated cells. The same filter was reprobed with anti-
gpl30 antibody to confirm that a comparable amount of 
gpl30 was present in the immunoprecipitates (Fig. 1A, mid-
dle). It was also confirmed that in cells stimulated by leptin, 
the downstream signal was indeed activated. As shown in the 
bottom panel of Fig. 1A, tyrosine phosphorylation of STAT3 
did occur in the leptin-stimulated COS7 transfectants. To fur-
ther examine whether LIFR is tyrosine phosphorylated in 
response to leptin, COS7 cells were transfected with the 
same set of expression constructs (OB-R, gpl30 and STAT3 
cDNAs) and treated with medium alone, leptin or LIF. The 
cell lysates were immunoprecipitated with anti-phosphotyro-
sine antibody and immunoblotted with anti-LIFR antibody 
(Fig. IB, upper). Leptin stimulation did not cause detectable 
tyrosine phosphorylation of LIFR, while LIF stimulation did. 
Comparable amounts of LIFR were detected in each cell ly-
sate (Fig. IB, lower). These results indicate that OB-R signal-
ing does not involve gpl30 or LIFR. 
3.2. Formation of OB-R homo-oligomer prior to leptin 
stimulation 
The results described above led us to consider the possibil-
ity that OB-R forms a homodimer as does gpl30. In order to 
examine this possibility, we prepared two differently epitope-
tagged OB-R molecules and investigated whether these two 
were coimmunoprecipitated. For this purpose we made two 
OB-R-based constructs tagged with FLAG (OBF) or c-Myc 
(OBM) at the cytoplasmic tail (see Section 2). These con-
structs were transfected into COS7 cells and the cells were 
treated with or without leptin as indicated in Fig. 2. The cells 
were solubilized and subjected to immunoprecipitation fol-
lowed by immunoblotting using either anti-FLAG or anti-c-
Myc antibodies. The OBF and OBM were efficiently expressed 
in COS7 cells and specifically recognized by anti-FLAG and 
anti-c-Myc antibodies, respectively (Fig. 2, upper). From the 
cells expressing both OBF and OBM, OBM was detected in 
the anti-FLAG immunoprecipitates, and so was OBF in the 
anti-c-Myc immunoprecipitates, regardless of leptin stimula-
tion (Fig. 2, lower). These results suggested that OB-R forms 
a homodimer or homo-oligomer with itself before leptin stim-
ulation. 
3.3. Leptin-induced DNA synthesis in BalF3 cells expressing 
OB-R 
The expression construct for the long form OB-R was sta-
bly transfected into IL-3-dependent mouse Ba/F3 cells which 
do not express endogenous gpl30 [38]. As shown in Fig. 3, 
leptin stimulation led to increased DNA synthesis in the OB-
R transfectants but not in the parental cells. Parental and OB-
R-transfected Ba/F3 cells exhibited a similar increase of DNA 
synthesis in response to IL-3 (data not shown). Since Ba/F3 
cells do not express gpl30, the results suggested that OB-R 
transduces the leptin signal without any help from gpl30. 
4. Discussion 
The IL-6 family of cytokines induce dimerization of gpl30 
with itself or with closely related LIFR [6,7]. The dimerization 
leads to activation of receptor-associated JAKs, and activated 
JAKs then tyrosine phosphorylate gpl30 and LIFR as a first 
signal transducing event [8,16,20,21]. gpl30 and LIFR under-
go no detectable tyrosine phosphorylation by OB-R stimula-
tion, indicating that OB-R may share neither of them in the 
functional OB-R complex. From the experiments with two 
differently epitope-tagged OB-R molecules, it is implied that 
OB-R forms a homodimer or homo-oligomer in the absence 
of leptin at least in COS7 cells. In contrast, the overexpression 
of gpl30 does not lead to its homo-oligomerization prior to 
stimulation [8]. It remains to be examined whether OB-R 
homo-oligomerization also occurs in normal untransfected 
cells. OB-R-expressing Ba/F3 cells exhibited DNA synthesis 
in response to leptin, without any expression of endogenous 
gpl30 molecule. These results suggest that OB-R transduces 
the signal through its homodimerization or homo-oligomeri-
zation but not via the interaction with gpl30 or LIFR. The 
stoichiometry of OB-R multimerization remains to be deter-
mined. 
In that case, how does OB-R transduce the leptin signal? 
OB-R homo-oligomer preformed in the absence of leptin re-
quires leptin stimulation for triggering cytoplasmic signaling, 
since tyrosine phosphorylation of STAT3 was observed only 
after leptin treatment (see Fig. 1). Ligand-independent homo-
dimerization or homo-oligomerization of cytokine receptors 
has previously been reported. Granulocyte-macrophage col-
ony-stimulating factor (GM-CSF) receptor ß [39] and IL-12 
receptor [40,41], both of which are members of the class I 
cytokine receptor family, have been shown to form homo-
dimer or homo-oligomer prior to their ligand stimulation. 
However, dimerization or oligomerization are insufficient for 
signaling [39^41]. In the case of GM-CSFRß, the homodimer 
further forms a functional GM-CSFR with another subunit (a 
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subunit) in response to G M - C S F [39]. As for IL-12R, the 
presence of a thus far unidentified subunit has been suggested 
to be included in the functional IL-12R, since the cloned IL-
12R, when expressed in Ba/F3 cells, indeed forms homodimer 
or homo-oligomer and confers high-affinity IL-12-binding 
sites but is incapable of mediating D N A synthesis [40,41]. 
This is in marked contrast to the IL-6-induced gpl30 homo-
dimer, which mediates D N A synthesis when expressed in Ba/ 
F3 cells [18,38]. As concerns OB-R, it is capable of transduc-
ing the leptin signal when transfected in COSI , COS7, H-35, 
Hep3B, HepG2, and Ba/F3 cells ([31,32], and this paper). It 
should be possible that the pre-formed OB-R homo-oligomer 
may further associate with an unidentified receptor compo-
nent which is expressed in these cells. Alternatively, leptin 
stimulation may induce conformational change in the pre-
formed OB-R homo-oligomer to activate cytoplasmic signal-
ing cascades. 
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